Skip to content

InsiderTradesSIGMA

RecommendationsTOP BasketNEW TerminalNEW

Companies Executives Screeners Performance Blog

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Free account open.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 23 markets

Recommendations
Terminal
Companies
Insiders
Performance
Backtest
Data quality

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive
Insider buying this week
Cluster signals

Methodology
How it works
Glossary
API docs
Blog
RSS
Screeners
Newsletter
Key facts
Data
Insider Confidence Index

About
Contact
Pricing
Sign in
Privacy
Terms
Cookies

Built in Paris. Public sources across 43 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa, among others. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-27. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Free account open · Pro on waitlist·Hosted on Vercel

Built bySimon Azoulay

All systems operational

US-Listed Companies · SEC (Form 4) · InsiderTrades Sigma · page 111

US11,623 companies

US-Listed Companies

Regulator: SEC (Form 4).

Idexx Laboratories INC /de

Santé & Pharma · 43.7B

Ikena Oncology, Inc.

Santé & Pharma

Illinois Tool Works INC

Industrie · 79.8B

Santé & Pharma · 32.3B

Image Sensing Systems INC

ImageneBio, Inc.

Imageware Systems INC

Technologie · 34.8k

Imago BioSciences, Inc.

Santé & Pharma

Technologie · 243.3M

Previous 1...100...109 110111112 113...120 130 140 150...233 Next

Immix Biopharma, Inc.

Santé & Pharma · 998.8M

Santé & Pharma · 99.3M

Immune Design Corp.

Immune Therapeutics, Inc.

Santé & Pharma

Immuneering Corp

Santé & Pharma · 322.8M

Santé & Pharma · 194.8M

ImmunityBio, Inc.

Santé & Pharma · 8.5B

ImmunoGen, Inc.

Santé & Pharma

Immunocore Holdings plc

Santé & Pharma · 3.1B

Immunovant, Inc.

Santé & Pharma · 8.5B

Impac Mortgage Holdings INC

Finance & Banque

Impel Neuropharma INC

Santé & Pharma

Imperalis Holding CORP.

Imperial Petroleum Inc./Marshall Islands

Imprimis Pharmaceuticals, Inc.

InFinT Acquisition Corp

InMed Pharmaceuticals Inc.

Santé & Pharma · 7.2M

InPoint Commercial Real Estate Income, Inc.

Immobilier · 89.8M

Inari Medical, Inc.

Santé & Pharma

Incannex Healthcare Inc.

Inception Growth Acquisition Ltd

Inception Mining INC.

Indaptus Therapeutics, Inc.

Santé & Pharma · 157.2M

Independence Contract Drilling, Inc.

Independence Holding Co

Finance & Banque

Independence Realty Trust, INC.

Immobilier · 3.9B

Independent Bank CORP

Finance & Banque · 3.9B

Independent Bank Corp.

Independent Bank Group, Inc.

Finance & Banque

India Globalization Capital, Inc.

Santé & Pharma · 23.1M

India Globalization Capital, Inc.

Santé & Pharma · 23.1M

India Globalization Capital, Inc.

Santé & Pharma · 23.1M

Indivior Pharmaceuticals, Inc.

Santé & Pharma · 4.1B

Indivior Pharmaceuticals, Inc.

Santé & Pharma · 4.1B